OPCH vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 20, 2026

OPCH

30.0
AI Score
VS
PACS Wins

PACS

33.9
AI Score

Investment Advisor Scores

OPCH

30score
Recommendation
SELL

PACS

34score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric OPCH PACS Winner
Revenue 4.18B 2.85B OPCH
Net Income 149.08M 157.06M PACS
Net Margin 3.6% 5.5% PACS
Operating Income 246.41M 229.37M OPCH
ROE 11.0% 14.1% PACS
ROA 4.3% 2.8% OPCH
Total Assets 3.48B 5.66B PACS
Cash 309.82M 164.45M OPCH
Debt/Equity 0.86 0.21 PACS
Current Ratio 1.56 0.91 OPCH

Relative Price Performance (Last 90 Days)

OPCH 1M: +36.2% · 3M: +43.3% PACS 1M: +15.7% · 3M: +1.8%

Current Technical Phase

OPCH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (9.9% over 20 days), RSI 83

RSI (14): 82.5 · Price: $31.25

PACS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 64

RSI (14): 64.4 · Price: $47.95

Fundamentals Snapshot

Metric OPCH PACS
Market Cap — —
Forward P/E 15.0 17.4
Trailing P/E 23.7 27.3
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.1%
EPS 1.32 1.71
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PACS is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.